Holen Sie sich die Stockscreener-App
49.80
2.66%
1.29
Handel nachbörslich:
49.80
Schlusskurs vom Vortag:
$48.51
Offen:
$48.01
24-Stunden-Volumen:
516.68K
Relative Volume:
1.02
Marktkapitalisierung:
$2.29B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$-20.76M
KGV:
-64.68
EPS:
-0.77
Netto-Cashflow:
$151.63M
1W Leistung:
+24.13%
1M Leistung:
+17.48%
6M Leistung:
+65.28%
1J Leistung:
+63.60%
1-Tages-Spanne:
$48.01
$50.20
1-Wochen-Bereich:
$45.15
$55.74
52-Wochen-Spanne:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Omnicell's SWOT analysis: healthcare tech firm's stock rides upgrade wave - Investing.com
Omnicell's SWOT analysis: healthcare tech firm's stock rides upgrade wave By Investing.com - Investing.com UK
Omnicell, Inc. (NASDAQ:OMCL) Q3 2024 Earnings Call Transcript - MSN
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? - Benzinga
Omnicell Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next - Simply Wall St
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised - MSN
Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out? - MSN
Rice Hall James & Associates LLC Invests $2.72 Million in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell Appoints Nnamdi Njoku as Executive Vice President and C - GuruFocus.com
Omnicell cut to neutral by BofA, lack of visibility into growth cited - MSN
Omnicell Q3 Earnings: Look At The Growth Segment (NASDAQ:OMCL) - Seeking Alpha
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL) - Yahoo Finance
What 5 Analyst Ratings Have To Say About Omnicell - Benzinga
Omnicell (NASDAQ:OMCL) Price Target Raised to $58.00 - MarketBeat
Omnicell stock hits 52-week high at $45.85 amid market rally - Investing.com Australia
Omnicell's (OMCL) Neutral Rating Reaffirmed at Bank of America - MarketBeat
42,461 Shares in Omnicell, Inc. (NASDAQ:OMCL) Acquired by Roubaix Capital LLC - MarketBeat
Omnicell stock downgraded at BofA on growth visibility concerns - Investing.com
Omnicell Inc (OMCL) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance Australia
Omnicell stock downgraded at BofA on growth visibility concerns By Investing.com - Investing.com UK
Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)? - Simply Wall St
Omnicell Inc (OMCL) Q3 2024 Earnings: EPS at $0.19 Beats Estimat - GuruFocus.com
Omnicell Reports Strong Q3 2024 Financial Results - TipRanks
Top Medical Stock Breaks Out After Obliterating Profit Views - Investor's Business Daily
Omnicell stock hits 52-week high at $45.85 amid market rally By Investing.com - Investing.com South Africa
Omnicell soars after bullish quarterly report, outlook - XM
Omnicell (OMCL) Beats Q3 Earnings and Revenue Estimates - MSN
Omnicell Q3 2024 Earnings Preview - MSN
Omnicell (NASDAQ:OMCL) Reaches New 52-Week HighWhat's Next? - MarketBeat
Omnicell earnings beat by $0.14, revenue topped estimates - Investing.com Canada
Omnicell Announces Third Quarter 2024 Results - citybiz
Omnicell (NASDAQ:OMCL) Issues Q4 Earnings Guidance - MarketBeat
Omnicell earnings beat by $0.14, revenue topped estimates By Investing.com - Investing.com South Africa
Omnicell beats Q3 expectations, raises full-year outlook By Investing.com - Investing.com Australia
Omnicell: Q3 Earnings Snapshot - Thehour.com
Omnicell beats Q3 expectations, raises full-year outlook - Investing.com India
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell - Yahoo Finance
3 Medical Info Systems Stocks to Gain From Healthcare Digitization - Yahoo Finance
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
When the Price of (OMCL) Talks, People Listen - Stock Traders Daily
GAM Holding AG Sells 30,371 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell (OMCL) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Omnicell (OMCL) Moves to Strong Buy: Rationale Behind the Upgrade - MSN
Omnicell (NASDAQ:OMCL) Upgraded to Buy at StockNews.com - MarketBeat
New Horizons in Senior Healthcare Medication Services Market - openPR
Central Fill Pharmacy Automation Market Growth in Future Scope - openPR
Wells Fargo & Company Increases Omnicell (NASDAQ:OMCL) Price Target to $41.00 - Defense World
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Position Trimmed by Exchange Traded Concepts LLC - MarketBeat
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):